Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines

Based on the two main frameworks for evaluating scientific evidence (SEC and GRADE) European cardiovascular prevention guidelines recommend interventions across all life stages using a combination of population-based and high-risk strategies with diet as the cornerstone of prevention. The evaluation...

Descripción completa

Detalles Bibliográficos
Autores: Royo-Bordonada, MA, Bejarano, JML, Alvarez, FV, Sans, S, Perez, A, Pedro-Botet, J, Carriles, RMM, Maiques, A, Lizcano, A, Lizarbe, V, Nunez, AG, Ubeda, FF, Elosua, R, Nocito, AD, Zarzosa, CD, Moreno, FD, Cortes, O, Cordero, A, Babkowski, MC, Cuixart, CB, Armario, P
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p7380
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7380
Access Level:acceso abierto
Palabra clave:Cardiovascular prevention
Cardiovascular risk
Cardiovascular diseases
Clinical practice guidelines
id ES_8d5886906419a1eccbc04df344f8a35e
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p7380
network_acronym_str ES
network_name_str España
repository_id_str
spelling Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention GuidelinesRoyo-Bordonada, MABejarano, JMLAlvarez, FVSans, SPerez, APedro-Botet, JCarriles, RMMMaiques, ALizcano, ALizarbe, VNunez, AGUbeda, FFElosua, RNocito, ADZarzosa, CDMoreno, FDCortes, OCordero, ABabkowski, MCCuixart, CBArmario, PCardiovascular preventionCardiovascular riskCardiovascular diseasesClinical practice guidelinesBased on the two main frameworks for evaluating scientific evidence (SEC and GRADE) European cardiovascular prevention guidelines recommend interventions across all life stages using a combination of population-based and high-risk strategies with diet as the cornerstone of prevention. The evaluation of cardiovascular risk (CVR) incorporates HDL levels and psychosocial factors, a very high risk category, and the concept of age-risk. They also recommend cognitive-behavioural methods (e.g., motivational interviewing, psychological interventions) led by health professionals and with the participation of the patient's family, to counterbalance psychosocial stress and reduce CVR through the institution of positive habits such as a healthy diet, physical activity, smoking cessation, and adherence to treatment. Additionally, public health interventions such as smoking ban in public areas or the elimination of trans fatty acids from the food chain are also essential. Other innovations include abandoning antiplatelet therapy in primary prevention and the recommendation of maintaining blood pressure within the 130-139/80-85 mmHg range in diabetic patients and individuals with high CVR. Finally, due to the significant impact on patient progress and medical costs, special emphasis is given to the low therapeutic adherence levels observed. In sum, improving cardiovascular prevention requires a true partnership among the political class, public administrations, scientific and professional associations, health foundations, consumer associations, patients and their families. Such partnership would promote population-based and individual strategies by taking advantage of the broad spectrum of scientific evidence available, from clinical trials to observational studies and mathematical models to evaluate population-based interventions, including cost-effectiveness analyses. (C) 2013 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L.U. All rights reserved.ELSEVIER ESPANA SLU2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7380NEUROLOGIAISSN: 02134853ISSNe: 15781968reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Españolinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p73802026-06-14T12:41:47Z
dc.title.none.fl_str_mv Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
title Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
spellingShingle Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
Royo-Bordonada, MA
Cardiovascular prevention
Cardiovascular risk
Cardiovascular diseases
Clinical practice guidelines
title_short Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
title_full Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
title_fullStr Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
title_full_unstemmed Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
title_sort Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines
dc.creator.none.fl_str_mv Royo-Bordonada, MA
Bejarano, JML
Alvarez, FV
Sans, S
Perez, A
Pedro-Botet, J
Carriles, RMM
Maiques, A
Lizcano, A
Lizarbe, V
Nunez, AG
Ubeda, FF
Elosua, R
Nocito, AD
Zarzosa, CD
Moreno, FD
Cortes, O
Cordero, A
Babkowski, MC
Cuixart, CB
Armario, P
author Royo-Bordonada, MA
author_facet Royo-Bordonada, MA
Bejarano, JML
Alvarez, FV
Sans, S
Perez, A
Pedro-Botet, J
Carriles, RMM
Maiques, A
Lizcano, A
Lizarbe, V
Nunez, AG
Ubeda, FF
Elosua, R
Nocito, AD
Zarzosa, CD
Moreno, FD
Cortes, O
Cordero, A
Babkowski, MC
Cuixart, CB
Armario, P
author_role author
author2 Bejarano, JML
Alvarez, FV
Sans, S
Perez, A
Pedro-Botet, J
Carriles, RMM
Maiques, A
Lizcano, A
Lizarbe, V
Nunez, AG
Ubeda, FF
Elosua, R
Nocito, AD
Zarzosa, CD
Moreno, FD
Cortes, O
Cordero, A
Babkowski, MC
Cuixart, CB
Armario, P
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Cardiovascular prevention
Cardiovascular risk
Cardiovascular diseases
Clinical practice guidelines
topic Cardiovascular prevention
Cardiovascular risk
Cardiovascular diseases
Clinical practice guidelines
description Based on the two main frameworks for evaluating scientific evidence (SEC and GRADE) European cardiovascular prevention guidelines recommend interventions across all life stages using a combination of population-based and high-risk strategies with diet as the cornerstone of prevention. The evaluation of cardiovascular risk (CVR) incorporates HDL levels and psychosocial factors, a very high risk category, and the concept of age-risk. They also recommend cognitive-behavioural methods (e.g., motivational interviewing, psychological interventions) led by health professionals and with the participation of the patient's family, to counterbalance psychosocial stress and reduce CVR through the institution of positive habits such as a healthy diet, physical activity, smoking cessation, and adherence to treatment. Additionally, public health interventions such as smoking ban in public areas or the elimination of trans fatty acids from the food chain are also essential. Other innovations include abandoning antiplatelet therapy in primary prevention and the recommendation of maintaining blood pressure within the 130-139/80-85 mmHg range in diabetic patients and individuals with high CVR. Finally, due to the significant impact on patient progress and medical costs, special emphasis is given to the low therapeutic adherence levels observed. In sum, improving cardiovascular prevention requires a true partnership among the political class, public administrations, scientific and professional associations, health foundations, consumer associations, patients and their families. Such partnership would promote population-based and individual strategies by taking advantage of the broad spectrum of scientific evidence available, from clinical trials to observational studies and mathematical models to evaluate population-based interventions, including cost-effectiveness analyses. (C) 2013 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L.U. All rights reserved.
publishDate 2016
dc.date.none.fl_str_mv 2016
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7380
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=7380
dc.language.none.fl_str_mv Español
language_invalid_str_mv Español
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv ELSEVIER ESPANA SLU
publisher.none.fl_str_mv ELSEVIER ESPANA SLU
dc.source.none.fl_str_mv NEUROLOGIA
ISSN: 02134853
ISSNe: 15781968
reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869413037865172992
score 15,812429

Similares en LA Referencia